Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Olfaction Disorders | 19 | 2023 | 224 | 4.100 |
Why?
|
Olfactory Mucosa | 15 | 2022 | 101 | 2.730 |
Why?
|
Olfactory Bulb | 7 | 2023 | 198 | 2.300 |
Why?
|
Smell | 11 | 2023 | 259 | 2.040 |
Why?
|
Sinusitis | 20 | 2023 | 991 | 1.820 |
Why?
|
Rhinitis | 17 | 2023 | 747 | 1.630 |
Why?
|
Olfactory Receptor Neurons | 4 | 2022 | 96 | 1.580 |
Why?
|
Paranasal Sinus Diseases | 5 | 2015 | 121 | 1.130 |
Why?
|
Paranasal Sinus Neoplasms | 5 | 2023 | 242 | 1.060 |
Why?
|
Endoscopy | 16 | 2023 | 1851 | 1.050 |
Why?
|
Esthesioneuroblastoma, Olfactory | 3 | 2023 | 58 | 1.020 |
Why?
|
Nasal Cavity | 6 | 2024 | 304 | 1.020 |
Why?
|
Epistaxis | 5 | 2020 | 112 | 0.910 |
Why?
|
Nose Neoplasms | 3 | 2023 | 249 | 0.860 |
Why?
|
Rodentia | 1 | 2023 | 262 | 0.750 |
Why?
|
Coloring Agents | 1 | 2023 | 559 | 0.700 |
Why?
|
Cranial Nerves | 1 | 2019 | 98 | 0.650 |
Why?
|
Implantable Neurostimulators | 1 | 2019 | 75 | 0.640 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 3 | 2022 | 141 | 0.580 |
Why?
|
Hydrocarbons, Brominated | 1 | 2014 | 29 | 0.480 |
Why?
|
Turbinates | 4 | 2019 | 64 | 0.480 |
Why?
|
Paranasal Sinuses | 7 | 2021 | 265 | 0.450 |
Why?
|
Nasal Polyps | 6 | 2018 | 395 | 0.450 |
Why?
|
Frontal Sinus | 1 | 2013 | 51 | 0.440 |
Why?
|
Electric Stimulation Therapy | 1 | 2018 | 628 | 0.410 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2012 | 87 | 0.410 |
Why?
|
Quality of Life | 15 | 2023 | 13361 | 0.390 |
Why?
|
Maxillary Sinus | 4 | 2023 | 180 | 0.390 |
Why?
|
Skull Base | 2 | 2022 | 292 | 0.380 |
Why?
|
Hematoma | 2 | 2013 | 768 | 0.360 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3082 | 0.360 |
Why?
|
Intracranial Pressure | 1 | 2012 | 324 | 0.360 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3202 | 0.350 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 3 | 2020 | 324 | 0.330 |
Why?
|
Sensory Receptor Cells | 1 | 2014 | 513 | 0.330 |
Why?
|
Bone Transplantation | 1 | 2013 | 929 | 0.310 |
Why?
|
Biopsy | 4 | 2016 | 6766 | 0.280 |
Why?
|
Nose Diseases | 2 | 2020 | 79 | 0.270 |
Why?
|
Nerve Regeneration | 4 | 2018 | 795 | 0.270 |
Why?
|
Neural Stem Cells | 3 | 2019 | 888 | 0.270 |
Why?
|
Chronic Disease | 16 | 2023 | 9320 | 0.270 |
Why?
|
Mycoses | 1 | 2009 | 386 | 0.260 |
Why?
|
Nose | 3 | 2024 | 521 | 0.260 |
Why?
|
Diagnostic Errors | 1 | 2013 | 1265 | 0.250 |
Why?
|
Otolaryngology | 3 | 2020 | 693 | 0.250 |
Why?
|
Rhinoplasty | 2 | 2019 | 238 | 0.250 |
Why?
|
Natural Orifice Endoscopic Surgery | 2 | 2019 | 119 | 0.250 |
Why?
|
Surgical Flaps | 1 | 2013 | 1671 | 0.240 |
Why?
|
Toxins, Biological | 1 | 2004 | 60 | 0.240 |
Why?
|
Ligation | 3 | 2020 | 448 | 0.220 |
Why?
|
Maxillary Sinusitis | 1 | 2023 | 41 | 0.220 |
Why?
|
Nasal Mucosa | 3 | 2015 | 415 | 0.210 |
Why?
|
Humans | 75 | 2024 | 761423 | 0.210 |
Why?
|
Embolization, Therapeutic | 1 | 2012 | 1418 | 0.210 |
Why?
|
Hypersensitivity | 2 | 2022 | 1158 | 0.210 |
Why?
|
Olfactory Perception | 2 | 2020 | 65 | 0.200 |
Why?
|
Toll-Like Receptor 3 | 2 | 2015 | 98 | 0.200 |
Why?
|
Cautery | 2 | 2020 | 71 | 0.190 |
Why?
|
Carcinoma | 2 | 2014 | 2330 | 0.190 |
Why?
|
Metaplasia | 1 | 2022 | 322 | 0.190 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2022 | 86 | 0.180 |
Why?
|
Immunohistochemistry | 4 | 2011 | 11073 | 0.180 |
Why?
|
Aerosols | 2 | 2020 | 635 | 0.180 |
Why?
|
Aged | 28 | 2023 | 169235 | 0.180 |
Why?
|
Axons | 3 | 2005 | 1674 | 0.180 |
Why?
|
Dysgeusia | 1 | 2020 | 15 | 0.180 |
Why?
|
Skull Base Neoplasms | 1 | 2024 | 270 | 0.180 |
Why?
|
Nasal Septum | 2 | 2019 | 130 | 0.180 |
Why?
|
Olfactory Marker Protein | 3 | 2016 | 12 | 0.180 |
Why?
|
Metals | 1 | 2004 | 718 | 0.170 |
Why?
|
Medication Therapy Management | 1 | 2021 | 130 | 0.170 |
Why?
|
Melanosis | 1 | 2021 | 93 | 0.170 |
Why?
|
Otitis Media | 1 | 2022 | 287 | 0.170 |
Why?
|
Peroxidase | 1 | 2023 | 609 | 0.170 |
Why?
|
Ethmoid Bone | 1 | 2018 | 35 | 0.160 |
Why?
|
Middle Aged | 36 | 2023 | 220826 | 0.160 |
Why?
|
Staining and Labeling | 1 | 2023 | 1084 | 0.150 |
Why?
|
Optic Nerve Diseases | 1 | 2022 | 342 | 0.150 |
Why?
|
Postoperative Complications | 4 | 2018 | 15650 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2022 | 407 | 0.150 |
Why?
|
Hyperplasia | 1 | 2021 | 1152 | 0.150 |
Why?
|
Vitamin A | 1 | 2021 | 613 | 0.150 |
Why?
|
Olfactory Nerve | 3 | 2006 | 21 | 0.150 |
Why?
|
Melanocytes | 1 | 2021 | 509 | 0.140 |
Why?
|
Adult | 30 | 2023 | 221148 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
Male | 42 | 2023 | 360736 | 0.140 |
Why?
|
Nasal Obstruction | 1 | 2019 | 159 | 0.140 |
Why?
|
Cocaine | 1 | 2022 | 958 | 0.140 |
Why?
|
Meningomyelocele | 1 | 2018 | 171 | 0.140 |
Why?
|
Verapamil | 1 | 2017 | 242 | 0.130 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 654 | 0.130 |
Why?
|
Graves Ophthalmopathy | 1 | 2018 | 133 | 0.130 |
Why?
|
Papilloma, Inverted | 1 | 2015 | 19 | 0.130 |
Why?
|
Dacryocystorhinostomy | 1 | 2016 | 78 | 0.130 |
Why?
|
Steroids | 1 | 2021 | 929 | 0.130 |
Why?
|
S100 Proteins | 1 | 2016 | 218 | 0.120 |
Why?
|
Enophthalmos | 1 | 2015 | 34 | 0.120 |
Why?
|
Neurogenesis | 2 | 2019 | 862 | 0.120 |
Why?
|
Meningioma | 1 | 2024 | 1218 | 0.120 |
Why?
|
Treatment Outcome | 15 | 2024 | 64651 | 0.120 |
Why?
|
Female | 38 | 2023 | 392581 | 0.120 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2016 | 198 | 0.120 |
Why?
|
Meningeal Neoplasms | 1 | 2024 | 1248 | 0.120 |
Why?
|
Mice, Congenic | 1 | 2014 | 97 | 0.120 |
Why?
|
Neurons | 3 | 2023 | 9462 | 0.120 |
Why?
|
Thyroid Neoplasms | 1 | 2008 | 2332 | 0.120 |
Why?
|
Quality Improvement | 2 | 2020 | 3800 | 0.120 |
Why?
|
Cells | 1 | 1995 | 165 | 0.120 |
Why?
|
Eye Infections, Fungal | 1 | 2015 | 100 | 0.120 |
Why?
|
Mucormycosis | 1 | 2015 | 103 | 0.110 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2014 | 39 | 0.110 |
Why?
|
Airway Remodeling | 1 | 2015 | 133 | 0.110 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 450 | 0.110 |
Why?
|
Activins | 1 | 2015 | 210 | 0.110 |
Why?
|
Neurofilament Proteins | 1 | 2016 | 336 | 0.110 |
Why?
|
Pneumoencephalography | 1 | 2012 | 22 | 0.110 |
Why?
|
Catheterization | 1 | 2019 | 1432 | 0.110 |
Why?
|
Aspergillosis | 1 | 2015 | 242 | 0.110 |
Why?
|
Synaptic Transmission | 1 | 2019 | 1173 | 0.110 |
Why?
|
Orbital Diseases | 1 | 2015 | 178 | 0.110 |
Why?
|
Maxillary Artery | 1 | 2012 | 18 | 0.110 |
Why?
|
Decompression, Surgical | 1 | 2018 | 608 | 0.110 |
Why?
|
Olfactory Nerve Diseases | 1 | 2012 | 1 | 0.100 |
Why?
|
Anti-Bacterial Agents | 4 | 2022 | 7409 | 0.100 |
Why?
|
Pandemics | 6 | 2023 | 8641 | 0.100 |
Why?
|
Diagnosis, Differential | 6 | 2012 | 12970 | 0.100 |
Why?
|
Biological Products | 1 | 2021 | 912 | 0.100 |
Why?
|
Tubulin | 1 | 2016 | 693 | 0.100 |
Why?
|
Animals | 12 | 2023 | 168441 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1876 | 0.100 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.100 |
Why?
|
Orbit | 1 | 2015 | 457 | 0.100 |
Why?
|
Office Visits | 1 | 2016 | 595 | 0.100 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 629 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 7 | 2013 | 20556 | 0.090 |
Why?
|
Hamartoma | 1 | 2013 | 235 | 0.090 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2015 | 474 | 0.090 |
Why?
|
Headache | 1 | 2018 | 1256 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1600 | 0.090 |
Why?
|
Proteoglycans | 1 | 2013 | 803 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 823 | 0.090 |
Why?
|
Environmental Exposure | 1 | 2004 | 4467 | 0.080 |
Why?
|
Health Status Indicators | 1 | 2014 | 970 | 0.080 |
Why?
|
Complex Mixtures | 1 | 2008 | 29 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9277 | 0.080 |
Why?
|
Recovery of Function | 1 | 2018 | 2977 | 0.080 |
Why?
|
Microscopy, Electron | 2 | 2005 | 2561 | 0.080 |
Why?
|
Graft Survival | 2 | 2013 | 3819 | 0.080 |
Why?
|
Chemokine CCL5 | 1 | 2008 | 214 | 0.070 |
Why?
|
Aged, 80 and over | 9 | 2018 | 58956 | 0.070 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 1286 | 0.070 |
Why?
|
Consensus | 3 | 2022 | 3122 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39117 | 0.070 |
Why?
|
Mice | 6 | 2023 | 81509 | 0.070 |
Why?
|
Faculty, Medical | 1 | 2015 | 1202 | 0.070 |
Why?
|
Prospective Studies | 10 | 2023 | 54415 | 0.070 |
Why?
|
Physical Examination | 1 | 2012 | 1254 | 0.070 |
Why?
|
Debridement | 2 | 2022 | 493 | 0.070 |
Why?
|
Cadaver | 2 | 2020 | 1358 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9535 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7389 | 0.060 |
Why?
|
Blood Transfusion | 1 | 2012 | 1299 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1342 | 0.060 |
Why?
|
Young Adult | 7 | 2019 | 59207 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8633 | 0.060 |
Why?
|
Atlanto-Axial Joint | 1 | 2005 | 60 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2775 | 0.060 |
Why?
|
Neurodegenerative Diseases | 2 | 2021 | 1087 | 0.060 |
Why?
|
Sensory Thresholds | 1 | 2006 | 377 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2016 | 4414 | 0.060 |
Why?
|
Aging | 2 | 2018 | 8705 | 0.060 |
Why?
|
Sensation | 1 | 2006 | 337 | 0.060 |
Why?
|
Prognosis | 4 | 2018 | 29620 | 0.060 |
Why?
|
Glycoproteins | 1 | 2011 | 2208 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2024 | 80582 | 0.060 |
Why?
|
Neuroma | 1 | 2005 | 133 | 0.050 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2243 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15838 | 0.050 |
Why?
|
Tobacco Smoke Pollution | 1 | 2008 | 818 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2014 | 1610 | 0.050 |
Why?
|
Reoperation | 1 | 2012 | 4303 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11526 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5819 | 0.050 |
Why?
|
Wounds, Stab | 1 | 2001 | 72 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2003 | 459 | 0.050 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2001 | 122 | 0.050 |
Why?
|
Sneezing | 1 | 2020 | 17 | 0.040 |
Why?
|
Neck | 1 | 2005 | 734 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2023 | 590 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2021 | 384 | 0.040 |
Why?
|
Tampons, Surgical | 1 | 2020 | 10 | 0.040 |
Why?
|
Graft Rejection | 1 | 2013 | 4445 | 0.040 |
Why?
|
Hallucinations | 1 | 2023 | 366 | 0.040 |
Why?
|
Software | 1 | 2014 | 4434 | 0.040 |
Why?
|
Delphi Technique | 1 | 2023 | 846 | 0.040 |
Why?
|
GAP-43 Protein | 2 | 2013 | 152 | 0.040 |
Why?
|
Cohort Studies | 4 | 2015 | 41446 | 0.040 |
Why?
|
Taste | 1 | 2020 | 189 | 0.040 |
Why?
|
Optic Nerve | 1 | 2022 | 572 | 0.040 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3687 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9052 | 0.040 |
Why?
|
Nerve Degeneration | 2 | 2018 | 748 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2006 | 1010 | 0.040 |
Why?
|
Risk Factors | 6 | 2020 | 74167 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2021 | 657 | 0.040 |
Why?
|
Patient Satisfaction | 3 | 2014 | 3460 | 0.040 |
Why?
|
Diphtheria Toxin | 1 | 2018 | 253 | 0.040 |
Why?
|
Theophylline | 1 | 2017 | 131 | 0.040 |
Why?
|
Hemostatics | 1 | 2020 | 241 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 6966 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2008 | 3667 | 0.030 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2017 | 214 | 0.030 |
Why?
|
Preoperative Care | 1 | 2005 | 2242 | 0.030 |
Why?
|
Research Design | 2 | 2023 | 6178 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2013 | 36423 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2021 | 1834 | 0.030 |
Why?
|
Tretinoin | 1 | 2019 | 519 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1646 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15262 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22163 | 0.030 |
Why?
|
Electrophoresis | 1 | 1995 | 234 | 0.030 |
Why?
|
Regression Analysis | 1 | 2005 | 6343 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1116 | 0.030 |
Why?
|
Mucorales | 1 | 2015 | 35 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 93 | 0.030 |
Why?
|
Activities of Daily Living | 2 | 2014 | 2421 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1571 | 0.030 |
Why?
|
Needs Assessment | 1 | 2021 | 1139 | 0.030 |
Why?
|
Schizophrenia | 1 | 2013 | 6937 | 0.030 |
Why?
|
Risk | 2 | 2017 | 9612 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 165 | 0.030 |
Why?
|
Receptors, N-Acetylglucosamine | 1 | 2013 | 11 | 0.030 |
Why?
|
Versicans | 1 | 2013 | 40 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1815 | 0.030 |
Why?
|
Brain Injuries | 1 | 2006 | 2053 | 0.030 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2013 | 18 | 0.030 |
Why?
|
Time Factors | 4 | 2023 | 39975 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2017 | 22168 | 0.030 |
Why?
|
Plant Lectins | 1 | 2013 | 103 | 0.030 |
Why?
|
Recurrence | 2 | 2020 | 8469 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 2016 | 376 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21341 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2084 | 0.030 |
Why?
|
Private Practice | 1 | 2014 | 153 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10762 | 0.030 |
Why?
|
Gryllidae | 1 | 1992 | 20 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1606 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 14026 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1936 | 0.020 |
Why?
|
Hospitals, University | 1 | 2014 | 563 | 0.020 |
Why?
|
Transcription Factors | 1 | 2011 | 12125 | 0.020 |
Why?
|
Bandages | 1 | 2013 | 269 | 0.020 |
Why?
|
Epithelium | 1 | 1995 | 1603 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2022 | 2751 | 0.020 |
Why?
|
Angiofibroma | 1 | 2011 | 55 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11902 | 0.020 |
Why?
|
Pituitary Gland | 1 | 2013 | 635 | 0.020 |
Why?
|
Stem Cells | 1 | 2003 | 3522 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4912 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2015 | 752 | 0.020 |
Why?
|
Adolescent | 3 | 2014 | 88313 | 0.020 |
Why?
|
Pain | 1 | 2005 | 5071 | 0.020 |
Why?
|
Regeneration | 1 | 2019 | 1511 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14664 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2319 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2020 | 2220 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2856 | 0.020 |
Why?
|
Chemokine CCL7 | 1 | 2008 | 30 | 0.020 |
Why?
|
Immunochemistry | 1 | 2008 | 119 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2019 | 18964 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2001 | 8179 | 0.020 |
Why?
|
beta-Defensins | 1 | 2008 | 59 | 0.020 |
Why?
|
Skull | 1 | 2013 | 818 | 0.020 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2011 | 290 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2014 | 1722 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2014 | 1119 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 1992 | 1235 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2017 | 1588 | 0.020 |
Why?
|
Antibodies | 1 | 1995 | 2421 | 0.020 |
Why?
|
RNA, Double-Stranded | 1 | 2008 | 294 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4813 | 0.020 |
Why?
|
Interferon-beta | 1 | 2008 | 345 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3589 | 0.020 |
Why?
|
Air | 1 | 2006 | 187 | 0.020 |
Why?
|
Tonsillitis | 1 | 2005 | 28 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5115 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2008 | 695 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5776 | 0.020 |
Why?
|
Interferons | 1 | 2008 | 705 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2471 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3322 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9645 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2821 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13502 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7045 | 0.010 |
Why?
|
Rats | 2 | 2001 | 23742 | 0.010 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2003 | 14 | 0.010 |
Why?
|
Interleukins | 1 | 2008 | 782 | 0.010 |
Why?
|
Neck Pain | 1 | 2005 | 190 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6814 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6479 | 0.010 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2003 | 60 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2760 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2003 | 72 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10441 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2008 | 997 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8529 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 2003 | 393 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10089 | 0.010 |
Why?
|
Cell Surface Extensions | 1 | 2001 | 67 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2008 | 2207 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6238 | 0.010 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2001 | 263 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11106 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 1835 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3268 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2008 | 3207 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23990 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3530 | 0.010 |
Why?
|
Fever | 1 | 2005 | 1618 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4354 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5036 | 0.010 |
Why?
|
Brain | 1 | 2021 | 27107 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12796 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30045 | 0.010 |
Why?
|
Ultrasonics | 1 | 1992 | 207 | 0.010 |
Why?
|
United States | 1 | 2018 | 72339 | 0.010 |
Why?
|
Electrophysiology | 1 | 1992 | 1262 | 0.010 |
Why?
|
Muscles | 1 | 1992 | 1576 | 0.000 |
Why?
|
Electromyography | 1 | 1992 | 1393 | 0.000 |
Why?
|
Extremities | 1 | 1992 | 867 | 0.000 |
Why?
|
Movement | 1 | 1992 | 1478 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 9179 | 0.000 |
Why?
|
Child, Preschool | 1 | 2005 | 42254 | 0.000 |
Why?
|